You are in: eMedicine Specialties > Emergency Medicine > Ophthalmology
|
Corneal Ulceration and Ulcerative Keratitis Last Updated: November 15, 2006 |
|
| Synonyms and related keywords: corneal ulceration, ulcerative keratitis, corneal ulcer, peripheral ulcerative keratitis, PUK, corneal infiltrative events, CIEs, corneal ulcer disease, Mooren's ulcer, Mooren ulcer, corneal melt
|
|   |
AUTHOR INFORMATION
| Section 1 of 10  |
|
| Author: Jerome FX Naradzay, MD, FACEP, Emergency Services Medical Director, Department of Emergency Medicine, Maria Parham Medical Center Coauthor(s): Wesley S Grigsby, MD, Medical Director, Associate Clinical Professor, Department of Emergency Medicine, Creighton University |
| Jerome FX Naradzay, MD, FACEP, is a member of the following medical societies:
American College of Emergency Physicians, and
Society for Academic Emergency Medicine |
| Editor(s): William K Chiang, MD, Associate Professor, Department of Emergency Medicine, New York University School of Medicine; Consulting Staff, Department of Emergency Medicine, Bellevue Hospital Center; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine;
Douglas Lavenburg, MD, Clinical Professor, Department of Emergency Medicine, Christiana Care Health Systems;
John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School;
and Barry Brenner, MD, PhD, FACEP, Professor of Emergency Medicine, Professor of Internal Medicine, and Professor of Anatomy and Neurobiology, Research Director, Department of Emergency Medicine, University of Arkansas for Medical Sciences |
Disclosure
|   |
INTRODUCTION
| Section 2 of 10  |
|
Background: Because of its potential to permanently impair vision or perforate the eye, a corneal ulcer is considered an ophthalmologic emergency. While corneal ulcers occasionally may be sterile, most are infectious in etiology. Ulcers due to viral infection occur on a previously intact corneal epithelium. Bacterial corneal ulcers generally follow a traumatic break in the corneal epithelium, thereby providing an entry for bacteria. The traumatic episode may be minor, such as a minute abrasion from a small foreign body, or it may result from such causes as tear insufficiency, malnutrition, or contact lens use. Increased use of soft contact lenses in recent years has led to a dramatic rise in the occurrence of corneal ulcer, particularly due to Pseudomonas aeruginosa. In addition, with the introduction of topical corticosteroid drugs in the treatment of eye disease, fungal corneal ulcers have become more common.
Peripheral ulcerative keratitis (PUK) is a complication of rheumatoid arthritis (RA) that can lead to rapid corneal destruction (corneal melt) and perforation with loss of vision.
Mooren ulcer is a rapidly progressive, painful, ulcerative keratitis, which initially affects the peripheral cornea and may spread circumferentially and then centrally. Mooren ulcer can only be diagnosed in the absence of an infectious or systemic cause.
Pathophysiology: Klebsiella pneumoniae mucoid phenotype and its ability to form biofilm may be important in producing a corneal ulceration. Agents, such as N-acetylcysteine, may have a role in treatment because they inhibit biofilm formation.
Mooren ulcer is an idiopathic ulceration of the peripheral cornea, which may be due to an autoimmune reaction or it may be associated with the hepatitis C virus. Frequency:
Mortality/Morbidity: Corneal scarring and vision loss are possible.
Sex: Studies from the United Kingdom suggest that males who wear extended-wear contact lenses are at increased risk of forming a corneal ulcer.
Age: Corneal injury or infection can affect people of all ages.
However, young adults (aged 21-30 y) have been found to have a high incidence of corneal ulcer. This association is probably due to the fact that young adults are likely to use extended-wear contact lenses.
|   |
CLINICAL
| Section 3 of 10  |
|
History: Important information includes contact lens use, recent trauma, previous ocular surgery or injury, and presence of systemic or ocular disease. Question the patient regarding use of ocular medications such as topical steroids. - Erythema of eyelid and conjunctiva
- Contact lens profile - Extended wear, daily wear, worn during sleep, lens cleaning system
- Collagen vascular disease (rheumatoid arthritis)
- Exposure to sulphur mustard
- Inquiring about the dietary habits of a patient with a corneal ulcer is important because vitamin A deficiency is associated with corneal ulcer formation.
- Inadequate vitamin A can occur in a patient with an intentional diet deprivation or unintentional deprivation found in young children and pregnant women from Africa and Southeast Asia.
- Secondary vitamin A deficiency may be found in a patient with celiac disease, sprue, cystic fibrosis, pancreatic disease, duodenal bypass, congenital partial obstruction of the jejunum, obstruction of the bile ducts, giardiasis, and cirrhosis.
Physical: - Visual function is affected variably, depending on the location of the ulcer and whether associated corneal and uveal inflammation is present. Obtain visual acuities on all patients with ocular complaints.
- Examination of the lids and the conjunctiva may reveal associated inflammation in these locations.
- The eye is typically erythematous, and ciliary injection is often present. Pupillary constriction is usually present secondary to ciliary spasm and iritis.
- Purulent exudate may be seen in the conjunctival sac and on the surface of the ulcer, and infiltration of the stroma may result in a creamy opacity of the cornea. The ulcer often is round or oval, and the border generally is demarcated sharply, with the base appearing ragged and gray.
- Slit-lamp examination may reveal findings of iritis, and hypopyon may be present. Hypopyon is an accumulation of inflammatory cells in the anterior chamber that produces a layered meniscus in the inferior anterior chamber.
- Fluorescein staining may reveal the characteristic dendritic ulcer of herpes simplex virus (HSV) infection.
- A Wood lamp may be useful, since the ulcer associated with P aeruginosa fluoresces in ultraviolet light.
Causes: - Herpes simplex virus infection
- HSV is the most common cause of corneal ulcer in the US. Although not always present, the classic finding in HSV infection is a branching dendritic ulcer.
- Infection with HSV may interfere with corneal sensation, resulting in corneal anesthesia.
- Traumatic corneal injury
- Contact lenses, particularly soft lenses
- Chronic topical steroid use
- Varicella-zoster virus (VZV) infection
- VZV can cause a corneal ulcer. Although corneal involvement can occur in varicella (chickenpox), it is uncommon and typically benign. The form of zoster (shingles) involving the ophthalmic branch of the trigeminal nerve is a more common corneal infection caused by VZV.
- When herpetic eruption occurs along the nose, the nasociliary branch of the ophthalmic nerve is involved, indicating that corneal involvement is likely. This is known as the Hutchinson sign.
- The dendritic pattern seen in HSV infection is not seen with zoster infection, although pseudodendrites, which only vaguely resemble true dendrites, may be present. Loss of corneal sensation is a prominent feature of zoster infection.
- In contrast to the usual benign course in varicella and HSV, corneal complications in ophthalmic zoster can be severe and blinding.
- Bacterial infections
- Numerous bacteria have been reported to cause corneal ulcer, although staphylococcal species, P aeruginosa, Streptococcus pneumoniae, and Moraxella species are reportedly the most common causes in the US.
- Clinical characteristics of corneal ulcers caused by various bacteria are not sufficiently distinct to determine the causal bacterial agent, although a corneal ulcer having a bluish or green mucopurulent discharge is almost pathognomonic for P aeruginosa.
- Most corneal ulcers are centered, but some occur at the periphery of the cornea (ie, marginal ulcers).
- Although the location of the ulcer does not correlate well with the causative organism, a marginal ulcer is more likely to occur as a result of staphylococcal blepharoconjunctivitis. This ulcer is not due to direct bacterial infection but rather is an inflammatory reaction to staphylococcal bacterial antigens and toxins. The ulcer usually is self-limited and lasts from 7-10 days, but it is likely to recur unless the underlying blepharoconjunctivitis is treated.
- Fungal infections: Fungal ulcers are caused by Candida, Fusarium, Aspergillus, Penicillium, Cephalosporium, and mycosis fungoides species.
|   |
DIFFERENTIALS
| Section 4 of 10  |
|
Herpes Zoster Herpes Zoster Ophthalmicus
Other Problems to be Considered:
Corneal foreign body
Blepharitis
Mooren ulcer
Terrien degeneration
Herpes simplex keratitis |
|
|   |
WORKUP
| Section 5 of 10  |
|
Lab Studies:
- Rheumatoid arthritis evaluation
Other Tests:
- Scrapings of the ulcer may be necessary to identify the underlying organism. Place samples directly on culture media.
|   |
TREATMENT
| Section 6 of 10  |
|
Emergency Department Care: - Immediately obtain ophthalmologic consultation for all corneal ulcers, so that cultures may be taken and treatment initiated. Choice of medications should be left to the treating ophthalmologist but generally include broad-spectrum topical antibiotics and cycloplegic drops.
Consultations: - Corneal ulcers are considered an ophthalmologic emergency. Immediate ophthalmologic consultation is indicated.
|   |
MEDICATION
| Section 7 of 10  |
|
The first-line regimen usually consists of alternating an aminoglycoside with a first-generation cephalosporin every 15-30 min. Frequently used, ciprofloxacin 0.3% offers a shorter average time to healing and a reduced duration of therapy than conventional therapy. Obviously, the concern with this type of monotherapy is resistance.
Antibiotics may be administered by subconjunctival injection if compliance is a concern. To reduce the inhibition of corneal regeneration caused by concentrated antimicrobial solutions, the intervals between antimicrobial instillation and/or frequency of instillation should be prolonged following a decrease in purulence and a reduction in ulcer size.
If tests show that a viral infection is present, begin therapy with mechanical debridement of the infected rim along with a rim of the normal epithelium, followed by a topical instillation of the antiviral medications.
In fungal infections, a broad-spectrum antifungal drug usually is chosen. Some of the alternatives include natamycin, fluconazole, amphotericin B, miconazole, and ketoconazole. Natamycin is the first-line treatment in fungal infections of the cornea.
An adjunctive therapy may be required for conditions secondary to the ulcer. Atropine 1% or scopolamine 0.25% drops can be used to prevent formation of adhesions between the iris and the lens or cornea.
Topical corticosteroid use is controversial because its use in viral infections is relatively contraindicated, but it may prevent corneal scarring and perforation. Corticosteroids must be tapered to prevent rebound inflammation.
Hyperosmotics, carbonic anhydrase inhibitors, or beta-blockers can be administered if transient increases of intraocular pressure result from the keratitis.
Drug Category: Anesthetics -- Indicated for pain relief and for conjunctival and corneal scrapings. Local anesthetics stabilize the neuronal membrane and prevent the initiation and transmission of nerve impulses, thereby producing the local anesthetic action. Drug Name
| Proparacaine (Ophthetic, I-Paracaine) -- Has a rapid onset of anesthesia that begins within 13-30 sec after instillation. Short duration of action (about 15-20 min). Since prolonged eye anesthesia can eliminate the patient's awareness of mechanical damage to the cornea, do not use outside of the ED. Frequent use of anesthetics may retard healing. | | Adult Dose | 2-3 gtt q15-20min during ED examination 1-2 gtt q5-10min of 0.5% solution for 5-7 doses |
|---|
| Pediatric Dose | Administer as in adults |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | None reported |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Caution in cardiac disease or hyperthyroidism and with abnormal or reduced levels of plasma esterases |
|---|
Drug Category: Antibiotics -- Therapy must cover all likely pathogens in the context of the clinical setting.Drug Name
| Cefazolin (Ancef, Kefzol) -- First-generation cephalosporin antibiotic for gram-positive bacterial coverage. Commonly used in combination with an aminoglycoside to achieve broad-spectrum coverage.
This 50-133 mg/mL solution must be compounded| Adult Dose | 1-2 gtt q2-4h 50-133 mg/mL solution; not to exceed 2 gtt q1h for severe infections |
|---|
| Pediatric Dose | Administer as in adults |
|---|
| Contraindications | Documented hypersensitivity; viral, mycobacterial, and fungal infections of the eye; use of steroid combinations after uncomplicated removal of corneal foreign body |
|---|
| Interactions | None reported |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Not for use in ocular infections likely to become systemic; bacterial or fungal overgrowth of nonsusceptible organisms may occur with prolonged or repeated therapy |
|---|
|
|---|
Drug Name
| Gentamicin (Genoptic) -- Aminoglycoside antibiotic used for gram-negative bacterial coverage. Commonly used in combination with a first-generation cephalosporin. |
|---|
| Adult Dose | Ointment: 0.5-in (1.25-cm) ribbon bid/tid to q3-4h to the affected eye
Solution: 1-2 gtt q2-4h; not to exceed q1h for severe infections
This preparation should be fortified to a concentration of 15 mg/mL, which must be compounded| Pediatric Dose | Administer as in adults |
|---|
| Contraindications | Documented hypersensitivity; viral, mycobacterial, and fungal infections of the eye; use of steroid combinations after uncomplicated removal of a corneal foreign body |
|---|
| Interactions | None reported |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Do not use to treat ocular infections that may become systemic; prolonged or repeated antibiotic therapy may result in bacterial or fungal overgrowth of nonsusceptible organisms and may lead to a secondary infections |
|---|
|
|---|
Drug Name
| Erythromycin (E-Mycin, E.E.S.) -- Indicated for treatment of infections caused by susceptible strains of microorganisms and for prevention of corneal and conjunctival infections. |
|---|
| Adult Dose | 0.5-in (1.25-cm) ribbon 2-8 times/d, depending on severity of infection |
|---|
| Pediatric Dose | Administer as in adults |
|---|
| Contraindications | Documented hypersensitivity; viral, mycobacterial, and fungal infections of the eye; use of steroid combinations after uncomplicated removal of a corneal foreign body |
|---|
| Interactions | None reported |
|---|
| Pregnancy |
B - Usually safe but benefits must outweigh the risks.
|
|---|
| Precautions | Do not use topical antibiotics to treat ocular infections that may become systemic; prolonged or repeated antibiotic therapy may result in bacterial or fungal overgrowth of nonsusceptible organisms and may lead to a secondary infection (take appropriate measures if superinfection occurs) |
|---|
Drug Name
| Ciprofloxacin (Ciloxan) -- Bactericidal antibiotic that inhibits bacterial DNA synthesis, and consequently growth, by inhibiting DNA gyrase in susceptible organisms.
Indicated for pseudomonal infections and those due to multidrug-resistant gram-negative organisms.| Adult Dose | 1-2 gtt q1h while awake for 1 d; 1-2 gtt q4h while awake for another 7 d |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity; viral, mycobacterial, and fungal eye infections; use of steroid combinations after uncomplicated removal of a corneal foreign body |
|---|
| Interactions | None reported |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | A white crystalline precipitate located in the superficial portion of corneal defect may occur (onset in 1-7 d); precipitate is usually cleared within 2 wk and does not adversely affect clinical course or outcome; do not use in ocular infections that may become systemic; superinfections may occur with prolonged or repeated antibiotic therapy |
|---|
|
|---|
Drug Category: Antirheumatic, disease-modifying agents -- These agents are used in the treatment of rheumatoid arthritis associated corneal ulcer.Drug Name
| Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) -- Neutralizes cytokine TNF-alpha and inhibits its binding to TNF-alpha receptor. Mix in 250-mL normal saline for infusion over 2 h. Must use with low-protein-binding filter (1.2 micron or less). Indicated to reduce signs and symptoms of active ankylosing spondylitis. |
|---|
| Adult Dose | 5 mg/kg IV infusion at 0, 2, and 6 wk as induction regimen, then 5 mg/kg q6wk for maintenance
IV infusion must be administered over at least 2 h; must use infusion set with in-line, sterile, nonpyrogenic, low-protein-binding filter (pore size <1.2 microns)| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | None reported |
|---|
| Pregnancy |
B - Usually safe but benefits must outweigh the risks.
|
|---|
| Precautions | TNF-alpha modulates cellular immune responses; anti-TNF therapies, such as infliximab, may adversely affect normal immune responses and allow development of superinfections; more cases of lymphoma were observed in TNF alpha-blockers compared to controlled groups; may increase risk of reactivation of tuberculosis in patients with particular granulomatous infections |
|---|
|
|---|
Drug Category: Cycloplegics -- Instillation of a long-acting cycloplegic agent can relax any ciliary muscle spasm that can cause a deep aching pain and photophobia.Drug Name
| Scopolamine (Isopto Hyoscine) -- Blocks the action of acetylcholine at parasympathetic sites in the smooth muscle, producing pupillary dilation (mydriasis) and paralysis of accommodation (cycloplegia). |
|---|
| Adult Dose | 1-2 gtt qid |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity; primary glaucoma or initial stages of the disease |
|---|
| Interactions | None reported |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Avoid excessive systemic absorption by compressing lacrimal sac, using digital pressure for 1-3 min after instillation; may produce drowsiness, blurred vision or sensitivity to light (due to dilated pupils); observe caution while driving or performing other tasks requiring alertness, coordination, or physical dexterity |
|---|
Drug Category: Antivirals -- Therapy of viral infections begins with mechanical debridement of the involved rim along with a rim of normal epithelium. This is followed by the topical instillation of antiviral medications (eg, vidarabine, idoxuridine, trifluridine).Drug Name
| Vidarabine (Vira-A) -- Indicated as a topical idoxuridine or when toxic or hypersensitivity reactions to idoxuridine occur. Appears to interfere with the early steps of viral DNA synthesis. If no signs of improvement are evident after 7 d or if complete reepithelialization has not occurred in 21 d, consider other forms of therapy. Some severe cases may require longer treatment. After reepithelialization has occurred, treat for an additional 7 d at a reduced dosage (eg, twice daily) to prevent recurrence. |
|---|
| Adult Dose | 0.5-in (1.25-cm) ribbon q3h into lower conjunctival sac(s) 5 times/d |
|---|
| Pediatric Dose | Administer as in adults |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | None reported |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Viral resistance is possible but none reported |
|---|
Drug Name
| Idoxuridine (Herplex) -- Used for epithelial infections (especially initial attacks). Infections characterized by the presence of a dendritic shape respond better to this medication than stromal infections. Blocks the reproduction of HSV by producing incorrect DNA copies that prevent the virus from infecting or destroying the tissue. |
|---|
| Adult Dose | 1 gtt q1h during the day and q2h at night initially Continue until a definite improvement occurs, usually within 7 d Reduce dosage to 1 gtt q2h during the day and q4h at night To minimize recurrences, continue therapy at this reduced dosage for 3-7 d after healing appears complete; maximum treatment period is approximately 21 d Alternatively, 1 gtt/min for 5 min; repeat q4h, day and night |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | Coadministration with boric acid-containing solutions may result in a precipitate formation, which may cause irritation |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Since some strains of herpes simplex seem resistant, undertake another form of therapy if there is no lessening of fluorescein staining in 14 d; do not exceed recommended frequency and duration of administration |
|---|
Drug Category: Antifungals -- Broad-spectrum antifungal agents that cause minimal pain and corneal irritation are recommended. Natamycin is the first-line treatment in fungal infections of the cornea. Candidal infections refractory to natamycin may respond to amphotericin B, miconazole, fluconazole, and ketoconazole. Topical application of these drugs, however, is somewhat limited because most of them must be compounded.Drug Name
| Natamycin (Natacyn) -- Predominantly fungicidal tetraene polyene antibiotic, derived from Streptomyces natalensis that possesses in vitro activity against a variety of yeast and filamentous fungi, including Candida, Aspergillus, Cephalosporium, Fusarium, and Penicillium species. Binds fungal cell membrane forming a polyene sterol complex that alters membrane permeability and depleting essential cellular constituents. Activity against fungi is dose related, but it is not effective in vitro against gram-negative or gram-positive bacteria. Generally, therapy should be continued for 14-21 d or until the fungal keratitis has resolved. In many cases, reducing the dosage gradually at 4-7 d intervals may help ensure that the organism has been eliminated. |
|---|
| Adult Dose | 1 gtt into conjunctival sac q1-2h Frequency of application usually can be reduced to 1 gtt 6-8 times/d after the first 3-4 d |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | None reported |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Since some strains of herpes simplex seem resistant, undertake another form of therapy if there is no lessening of fluorescein staining in 14 d; do not exceed recommended frequency and duration of administration |
|---|
Drug Category: Nonsteroidal anti-inflammatory agents (NSAIDs) -- Mechanism of action is believed to be through inhibition of the cyclooxygenase enzyme that is essential in the biosynthesis of prostaglandins. Inhibition of prostaglandin synthesis results in vasoconstriction and decreases in vascular permeability, leukocytosis, and intraocular pressure (IOP). These agents, however, have no significant effect on IOP.Drug Name
| Ibuprofen (Ibuprin, Motrin, Advil) -- Usually the DOC for treatment of mild to moderate pain, if no contraindications exist. Inhibits inflammatory reactions and pain, probably by decreasing the activity of the enzyme cyclooxygenase, which results in prostaglandin synthesis. |
|---|
| Adult Dose | 200-400 mg PO q4-6h while symptoms persist; not to exceed 3.2 g/d |
|---|
| Pediatric Dose | 6 months to 12 years: 10-70 mg/kg/d PO divided tid/qid Start at the lower end of dosing range and titrate upward to a maximum of 2.4 g/d >12 years: Administer as in adults |
|---|
| Contraindications | Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency; high risk of bleeding |
|---|
| Interactions | Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
|---|
| Pregnancy |
B - Usually safe but benefits must outweigh the risks.
|
|---|
| Precautions | Category D in third trimester of pregnancy; caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy |
|---|
Drug Category: Analgesics -- Pain control is essential to quality patient care, ensuring patient comfort, promoting pulmonary toilet, and containing sedating properties that benefit patients who experience mild or severe pain.Drug Name
| Oxycodone and acetaminophen (Percocet) -- Drug combination indicated for the relief of moderate to severe pain. |
|---|
| Adult Dose | 1-2 tab or cap PO q4-6h prn |
|---|
| Pediatric Dose | 0.05-0.15 mg/kg/dose PO; not to exceed 5 mg/dose of oxycodone q4-6h prn |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | Phenothiazines may decrease analgesic effects; toxicity increases with coadministration of either CNS depressants or tricyclic antidepressants |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Duration of action may increase in the elderly; be aware of total daily dose of acetaminophen patient is receiving; do not exceed 4000 mg/d of acetaminophen; higher doses may cause liver toxicity |
|---|
|   |
FOLLOW-UP
| Section 8 of 10  |
|
Further Inpatient Care:
- The emergency physician should contact an ophthalmologist while the patient is still in the emergency department. Timely consultation can be arranged at this time.
Complications:
- The complications of corneal ulcer can be devastating. Corneal perforation, although rare, can occur. Corneal scarring may develop, resulting in partial or complete loss of vision. Anterior and posterior synechiae, glaucoma, and cataracts also can develop.
Prognosis:
- Corneal ulcerations should improve daily and should heal with appropriate therapy.
- If healing does not occur or the ulcer extends, consider an alternate diagnosis and treatment.
Patient Education:
|   |
MISCELLANEOUS
| Section 9 of 10  |
|
Medical/Legal Pitfalls:
- Attempting to treat in the ED and not obtaining an immediate ophthalmology consultation
|   |
BIBLIOGRAPHY
| Section 10 of 10 |
|
-
Araki-Sasaki K, Nishi I, Yonemura N: Characteristics of Pseudomonas corneal infection related to orthokeratology. Cornea 2005 Oct; 24(7): 861-3[Medline].
-
Clewes AR, Dawson JK, Kaye S: Peripheral ulcerative keratitis in rheumatoid arthritis: successful use of intravenous cyclophosphamide and comparison of clinical and serological characteristics. Ann Rheum Dis 2005 Jun; 64(6): 961-2[Medline].
-
Efron N, Morgan PB, Hill EA: Incidence and morbidity of hospital-presenting corneal infiltrative events associated with contact lens wear. Clin Exp Optom 2005 Jul; 88(4): 232-9[Medline].
-
Frith P, Gray R, MacLennan S: The eye in clinical practice. 1994; 77-95.
-
Goldberg DF, Negvesky GJ, Butrus SI: Ulcerative keratitis in mycosis fungoides. Eye Contact Lens 2005 Sep; 31(5): 219-20[Medline].
-
Hofling-Lima AL, de Freitas D, Sampaio JL: In vitro activity of fluoroquinolones against Mycobacterium abscessus and Mycobacterium chelonae causing infectious keratitis after LASIK in Brazil. Cornea 2005 Aug; 24(6): 730-4[Medline].
-
Int Ophthalmol Clin: Contact lenses and external disease. Int Ophthalmol Clin 1986; 26(1): 1-166[Medline].
-
Kehe K, Szinicz L: Medical aspects of sulphur mustard poisoning. Toxicology 2005 Oct 30; 214(3): 198-209[Medline].
-
Khanal B, Deb M, Panda A: Laboratory diagnosis in ulcerative keratitis. Ophthalmic Res 2005 May-Jun; 37(3): 123-7[Medline].
-
Krachmer JH, Mannis MJ, Holland EJ: Cornea: Fundamentals of Cornea and External Disease. 1997; 1: 403-407.
-
Leibowitz HM: Corneal Disorders: Clinical Diagnosis and Management. 1984; 353-372.
-
Mirza SH: Fungal keratitis due to fusarium solani. J Coll Physicians Surg Pak 2005 Sep; 15(9): 576-7[Medline].
-
Morgan PB, Efron N, Brennan NA: Risk factors for the development of corneal infiltrative events associated with contact lens wear. Invest Ophthalmol Vis Sci 2005 Sep; 46(9): 3136-43[Medline].
-
O'donnell C, Efron N: Contact lens wear and diabetes mellitus. Cont Lens Anterior Eye 1998; 21(1): 19-26[Medline].
-
Pichare A, Patwardhan N, Damle AS: Bacteriological and mycological study of corneal ulcers in and around Aurangabad. Indian J Pathol Microbiol 2004 Apr; 47(2): 284-6[Medline].
-
Pinna A, Sechi LA, Zanetti S: Detection of virulence factors in a corneal isolate of Klebsiella pneumoniae. Ophthalmology 2005 May; 112(5): 883-7[Medline].
-
Seino JY, Anderson SF: Mooren's ulcer. Optom Vis Sci 1998 Nov; 75(11): 783-90[Medline].
-
Servat JJ, Ramos-Esteban JC, Tauber S: Mycobacterium chelonae-Mycobacterium abscessus complex clear corneal wound infection with recurrent hypopyon and perforation after phacoemulsification and intraocular lens implantation. J Cataract Refract Surg 2005 Jul; 31(7): 1448-51[Medline].
-
Thomas JW, Pflugfelder SC: Therapy of progressive rheumatoid arthritis-associated corneal ulceration with infliximab. Cornea 2005 Aug; 24(6): 742-4[Medline].
-
Vaughan D, Asbury T, Riordan-Eva P: General Ophthalmology. 1995; 124-133.
-
Velasco Cruz AA, Attie-Castro FA, Fernandes SL: Adult blindness secondary to vitamin A deficiency associated with an eating disorder. Nutrition 2005 May; 21(5): 630-3[Medline].
-
Verhelst D, Koppen C, Van Looveren J: Clinical, epidemiological and cost aspects of contact lens related infectious keratitis in Belgium: results of a seven-year retrospective study. Bull Soc Belge Ophtalmol 2005; 7-15[Medline].
-
Zaher SS, Sandinha T, Roberts F: Herpes simplex keratitis misdiagnosed as rheumatoid arthritis-related peripheral ulcerative keratitis. Cornea 2005 Nov; 24(8): 1015-7[Medline].
Corneal Ulceration and Ulcerative Keratitis excerpt |